Диссертация (1141100), страница 18
Текст из файла (страница 18)
Vol. 21(3) - P. 180-9166.Heiligenhaus A., Miserocchi E., Heinz C., et al. Treatment of severeuveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonalantibody (rituximab)// Rheumatol (Oxford). – 2011. – Vol.50 – P.1390–4.67.Heiligenhaus A., Niewerth M., Ganser G., et al. Prevalence andcomplications of uveitis in juvenile idiopathic arthritis in a population-basednation-wide study in Germany: suggested modification of the current screeningguidelines // Rheumatology. – 2007. – Vol.46 – P.1015–968.Heinz C., Schumacher C., Roesel M., et al.. Elevated intraocularpressure in uveitis associated with juvenile idiopathic arthritis-associated uveitis,often detected after achieving inactivity // Br. J. Ophthalmol.
– 2012. - Vol.96 – P.140–169.Hermann G., Thon A., Mönkemöller K.Comorbidity of Type 1Diabetes and Juvenile Idiopathic Arthritis // The Journal of Pediatrics. – 2015. Vol. 166(4) - P.930–5.70.Hinks A., Barton A., John S., et al. Association between the PTPN22gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population:Further support that PTPN22 is an autoimmunity gene// Arthritis & Rheumatism –2005. – Vol.52 - P.1694–9.71.Hoeve M., KalininaAyuso V., Schalij-Delfos N.E., et al.
The clinicalcourse of juvenile idiopathic arthritis-associated uveitis in childhood and puberty //British Journal of Ophthalmology - 2012. – Vol.96 – P.852-6.72.Holland G. N. A reconsideration of anterior chamber flare and itsclinical relevance for children with chronic anterior uveitis (an AmericanOphthalmological Society thesis) // Trans. Am. Ophthalmol. Soc. – 2007.
Vol.105 – P.344–6473.Huang J.L., Yao T.C., See L.C. Prevalence of pediatric systemic lupuserythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide119prospective population-based study in Taiwan// ClinExpRheumatol. – 2004. –Vol.22 (6) – P.776–80.74.Hull K.M., Shoham N., Jae J., et al. The expanding spectrum ofsystemic autoinflammatory disorders and their rheumatic manifestations //CurrOpinRheumatol. – 2003. – Vol.15(1) – P.61-9.75.Jabs D.A., Nussenblatt R.B., Rosenbaum J.T.
Standardization ofUveitis Nomenclature (SUN) Working Group Standardization of uveitisnomenclature for reporting clinical data. Results of the First InternationalWorkshop// Am J Ophthalmol. – 2005. – Vol.140(3) – P.509–16.76.Kahn P., Weiss M., Imundo L., et al. Favorable response to high-doseinfliximab for refractory childhood uveitis // Ophthalmology.
– 2006. – Vol.113 –P. 860-4.77.Kaipiainen-Seppanen O., Savolainen A. Changes in the incidence ofjuvenile rheumatoid arthritis in Finland // Rheumatology (Oxford)-2001.-Vol.40(8) - 928–32.78.Kakkassery V., Mergler S., Pleyer U. Anti-TNF-alpha Treatment: APossible Promoter in Endogenous Uveitis? Observational Report on Six Patients:Occurrence of Uveitis Following Etanercept Treatment // Current Eye Research. –2010. – Vol.
35 - P.751-679.Kawada J., Ito Y., Torii Y., et al. Remission of juvenile idiopathicarthritis with primary Epstein-Barr virus infection // Rheumatology (Oxford) –2013. – Vol.52 – P.956–880.Kessler E.A., Becker M.L. Therapeutic advancements in juvenileidiopathic arthritis // Best Practice & Research Clinical Rheumatology – 2014. –Vol.28 (2)- P.293-31381.recentlyKotaniemi K., Kautiainen H., Karma A., et al. Occurrence of uveitis indiagnosedjuvenilechronicarthritis.Aprospectivestudy//Ophthalmology. – 2001. – Vol.108 – P.2071–5.12082.Krause M.L., Crowson C.S., Michet C.J., et al. Juvenile IdiopathicArthritis in Olmsted County, Minnesota, 1960–2013 // Arthritis & rheumatology(Hoboken, NJ) – 2016. – Vol.
68(1) – P.247-54.83.Kremer J.M. Cytotoxic T-lymphocyte antigen 4-immunoglobulin inrheumatoid arthritis// Rheum Dis Clin North Am.- 2004. – Vol. 30 – P.381–91.84.Kunjir V., Venugopalan A., Chodra A. Profile of Indian Patients withJuvenile Onset Chronic Inflammatory Joint Disease Using the ILAR ClassificationCriteria for JIA: A Community-based Cohort Study // The Journal ofRheumatology. – 2010. – Vol.37 (8) - P.1756 - 6285.La Mattina K.C., Goldstein D.A.
Adalimumab for the treatment ofuveitis// Expert Rev ClinImmunol. – 2017. – Vol.13(3) – P.181-8.86.Lanni S., Wood M., Ravelli A., et al. Towards a role of ultrasound inchildren with juvenile idiopathic arthritis // Rheumatology (Oxford) - 2013 – Vol.52 (3) – P. 413-20.87.Lehmann H.W., Plentz A., von Landenberg P., et al. Different patternsof disease manifestations of parvovirus B19-associated reactive juvenile arthritisand the induction of antiphospholipid antibodies // ClinRheumatol. – 2008.
– Vol.27 – P.333–888.Lerman M.A., Lewen M.D., Kempen J.H., et al. Uveitis reactivationin children treated with tumor necrosis factor alpha inhibitors// Am J Ophthalmol.– 2015. – Vol.160(1) – P.193–200.89.Lovell D.J., Giannini E.H., Reiff A. et al. Etanercept in children withpolyarticular juvenile rheumatoid arthritis.
Pediatric Rheumatology CollaborativeStudy Group // N Engl J Med. – 2000. - Vol. 342(11) – P.763-9.90.Luca N.J., Feldman B.M. Disease activity measures in paediatricrheumatic diseases// Int J Rheumatol. - 2013. – Vol.13 – P.1–1091.Manners P.J., Bower C. Worldwide prevalence of juvenile arthritiswhy does it vary so much? // J Rheumatol. - 2002. – Vol.29(7) - 1520–30.92.McKeever A., Kelly M.M.
Growing up with juvenile idiopathicarthritis // MCN Am J Matern Child Nurs. – 2015. – Vol.40(1) – P.8-15.12193.Merida S., Palacios E., Navea A., et al. : New ImmunosuppressiveTherapies in Uveitis Treatment // Int J Mol Sci. – 2015. – Vol.16(8) – P.18778–95.94.Merino R., De Inocencio J., García-Consuegra J. Evaluation of ILARclassification criteria for juvenile idiopathic arthritis in Spanish children //TheJournal of Rheumatology. – 2001.
– Vol. 28 (12) - P.2731-695.Müller L.O., Avenarius D., Damasio B., et al The paediatric wristrevisited: redefining MR findings in healthy children // Annals of the RheumaticDiseases. - 2011. – Vol. 70 – P.605-10.96.Nemeth E., Rivera S., Gabayan V. et al. IL-6 mediates hypoferremiaof inflammation by inducing the synthesis of the iron regulatory hormone hepcidin// J Clin Invest. – 2004. – Vol.
113 - P.1271–697.Nistala K., Babar J., Johnson K., et al. Clinical assessment and coreoutcome variables are poor predictors of hip arthritis diagnosed by MRI in juvenileidiopathic arthritis // Rheumatology (Oxford) - 2007. – Vol.46 (4) – P.699-702.98.Pettipher E.R., Higgs G.A., Henderson B.
Interleukin 1 inducesleukocyte infiltration and cartilage proteoglycan degradation in the synovial joint//Proceedings of the National Academy of Sciences of the United States of America.– 1986. – Vol. 83(22) – P.8749-53.99.Petty R.E., Cassidy J.T.
Textbook on pediatric rheumatology.Philadelphia: Saunders Elsevier; 2011100. Petty R.E., Southwood T.R., Manners P., et al. International League ofAssociations for Rheumatology Classification of Juvenile Idiopathic Arthritis:Second Revision, Edmonton, 2001 (Short Survey)// Journal of Rheumatology. –2004. -Vol.31 (2). – P.390-2101. Prahalad S., Glass D.N. A comprehensive review of the genetics ofjuvenile idiopathic arthritis // PediatrRheumatol Online J. – 2008 – Vol. 6 – P.11.102.
Ramanan Athimalaipet V., F.R.C.P.C.H., F.R.C.P., Andrew D. Dick,M.B., B.S., M.D., Ashley P. Jones, Ph.D., Andrew McKay, M.Sc., Paula R.Williamson, Ph.D., Sandrine Compeyrot-Lacassagne, M.D., Ben Hardwick,M.Res., Helen Hickey, B.Sc., Dyfrig Hughes, Ph.D., Patricia Woo, F.Med.Sci.,122Diana Benton, M.A., Clive Edelsten, M.R.C.P., F.R.C.Ophth., and Michael W.Beresford, M.B., Ch.B., Ph.D., for the SYCAMORE Study Group*Adalimumabplus Methotrexate for Uveitis in Juvenile Idiopathic ArthritisThe New EnglandJournal of Medicine Downloaded from nejm.org at AbbVie Library on April 26,2017.-P/1637-1646.103. Ravelli A., Martini A.
Juvenile idiopathic arthritis // Lancet. -2007. –Vol. 369 – P.767–78.104. Ravelli A., Minoia F., Davì S. Classification Criteria for MacrophageActivation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: AEuropeanLeagueRheumatology/PaediatricAgainstRheumatism/AmericanRheumatologyInternationalTrialsCollegeofOrganisationCollaborative Initiative // Arthritis Rheumatol. – 2016. – Vol.
68(3) – P.566-76.105. Ravelli A., Varnier G. C., Oliveira, S., et al. Antinuclear antibody–positive patients should be grouped as a separate category in the classification ofjuvenile idiopathic arthritis // Arthritis & Rheumatism. – 2011. – Vol. 63 – P. 267–75.106. Rigante D., Bosco A., Esposito S. The Etiology of Juvenile IdiopathicArthritis/ / Clinic Rev AllergImmunol. - 2015. – Vol.49(2) – P.253-61107. Ruperto N., Martini A.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
